Artemisinin combination therapies (ACTs) are used worldwide as first-line treatment against confirmed or suspected Plasmodium falciparum malaria. Despite the success of ACTs at reducing the global burden of malaria, emerging resistance to artemisinin threatens these gains. Countering onset of resistance might need deliberate tactics aimed at slowing the reduction in ACT effectiveness. We assessed optimum use of ACTs at the population level, specifically focusing on a strategy of multiple firs...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Copyright holder:
- Nguyen et al
- Copyright date:
© Nguyen et al. Open Access article distributed under the terms of CC BY.
articletitle: Optimum population-level use of artemisinin combination therapies: a modelling study
journaltitle: The Lancet Global Health
copyright: Copyright © 2015 Copyright © Nguyen et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.
Optimum population-level use of artemisinin combination therapies: a modelling study.
If you are the owner of this record, you can report an update to it here: Report update to this record